COVID-19 Research Paper Volume 14, Issue 1 pp 73—108
Decreased TMPRSS2 expression by SARS-CoV-2 predicts the poor prognosis of lung cancer patients through metabolic pathways and immune infiltration
Figure 3. Prognostic value of TMPRSS2 expression in lung cancer. (A) The OS, FPS and PPS of lung cancer patients were obtained from the Kaplan–Meier plotter database. (B) The OS and RFS of lung cancer cohorts obtained through the Prognoscan database. (C) Forest plots showing the associations between TMPRSS2 expression and various clinicopathological features of patients with lung cancer.